Maintenance of Response With Guselkumab for up to 3 Years’ Treatment in the Phase 3 VOYAGE 1 Trial of Patients With Plaque Psoriasis. J of Skin 2018, 2, S90. https://doi.org/10.25251/skin.2.supp.91.